Assessment of the efficacy and oncological safety of sentinel lymph node biopsy in node-negative breast cancer using methylene blue dye

Evaluation of sentinel lymph node biopsy using 1% methylene blue in node-responsive postneoadjuvant chemotherapy in patients with breast cancer

SUBAREOLAR VERSUS PERITUMORAL INJECTION OF METHYLENE BLUE FOR SENTINEL LYMPH NODE DETECTION IN CASES OF EARLY BREAST CANCER

SENTINEL LYMPH NODE BIOPSY USING METHYLENE BLUE DYE IN EARLY BREAST CANCER. IS IT TRULY RELIABLE?

Sentinel Lymph Node Biopsy in Early Breast Cancer Using Patent Blue Dye as a Single Identification Method: Experience of an Academic Center

Evaluation of the technique of endoscopic axillary sentinel lymph node biopsy in early-stage node-negative breast cancer

Implementation and evaluation of axillary reverse mapping technique in breast cancer patients using patent blue dye

Evaluation of the Efficacy of Combined Sentinel Lymph Node Biopsy Using Patent Blue Dye and Peripheral Lymph Node Biopsy in Management of Nodal Negative Early Breast Cancer

Evaluation of Sentinel Lymph Node Biopsy after Neoadjuvant Therapy for Breast Cancer Patients with Positive Axillary Nodes: A Multicenter Study

SENTINEL LYMPH NODE BIOPSY AFTER NEOADJUVANT CHEMOTHERAPY IN CLINICALLY NODE POSITIVE AXILLA OF BREAST CANCER